Dan Cohen

Dan Cohen is a highly experienced “crisis manager” and policy “fixer,” with years of service at the highest political levels globally.  He is the Chief Executive Officer of PainScript, Inc., an investment stage “telehealth” technology company seeking to improve patient treatment for substance use disorder (SUD) Pain Management and other chronic diseases, President of Optimus Healthcare Services (OTC PK:HOPS) and he serves as Chair of the Board of Directors for the MedStar National Rehabilitation Hospital Network, a 129 bed, $150m annual revenue specialty hospital and is a member of the Strategic Planning subcommittee of the MedStar Hospital Network Board of Directors.  He is the founder and former Chair of the US Abuse Deterrent Coalition, a “talk group” of over 30 Abuse Deterrence Formulations (ADF) “innovator” manufacturers, patient advocates and related organizations seeking to expand access to abuse deterrent/tamper resistant technologies in prescription opioids.

Previously, he served as the Executive Vice President, Government and Public Relations with KemPharm, Inc., a biopharmaceutical “Prodrug” company which develops and commercializes technology to create a diverse pipeline of therapeutics that target market opportunities in pain, attention deficit hyperactivity disorder and other central nervous system indications. Prior to that, he served as the Senior Vice President for Government Relations and Health Policy with EnteroMedics, an early-stage medical device company, he was part of the senior management team that led the successful 2015 FDA approval of the first new obesity medical device for consumers since 2001.